Prednisolon 10 mg JENAPHARM® clinical trials
4 indexed studies · 0 currently recruiting
- Ongoing, recruitingPhase II and Phase III (Integrated)
Phase II-III study to assess the efficacy and safety of sublingual immunotherapy in patients suffering from birch pollen allergy
This study looks at a spray treatment for birch pollen allergy. It wants to see if this spray, used under the tongue, can reduce symptoms like sneezing and itchy eyes, and if it's safe to use, compared to a dummy spray.
For: Moderate-to-severe allergic rhinitis / rhinoconjunctivitis due to birch pollen for at least two years according to the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelineGermany - Ongoing, recruitingTherapeutic confirmatory (Phase III)
Randomised placebo controlled clinical trial of efficacy of MYOcardial protection in postacute inFLAMmatory cardiac involvEment due to COVID-19 (MYOFLAME-19)
This study looks at new ways to protect the heart after inflammation caused by COVID-19. Researchers are testing two existing medicines to see if they can help improve heart function and reduce long-term problems. It aims to find better treatments for your heart post-COVID.
For: Inflammatory cardiovascular involvement due to COVID-19 · defined by Cardiovascular magnetic resonance imagingAustria · Germany - AuthorisedTherapeutic confirmatory (Phase III)
High Dose Steroids in Children with Stroke and Unilateral Focal Arteriopathy: A Multicentre Randomized Controlled Trial
This study looks at using strong steroid medicines to treat a type of stroke in children called focal cerebral arteriopathy (FCA). Researchers want to see if these medicines can reduce the inflammation in blood vessels and improve children's recovery.
For: Focal cerebral arteriopathy and childhood stroke Focal cerebral arteriopathy (FCA) is an inflammatory vessel wall disease provoked by infection.France · Austria · Germany - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Upadacitinib in Subjects with Giant Cell Arteritis
This study is testing a new medicine, upadacitinib, for giant cell arteritis (GCA). Researchers want to see if it can help people stay well and reduce the need for steroid medicines, comparing it to a dummy medicine.
For: Giant Cell ArteritisDenmark · Belgium · Germany